Clinical Trial Update: A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F) [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating Ifinatamab Deruxtecan in patients with advanced esophageal squamous cell carcinoma; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Ifinatamab Deruxtecan (Ifinatamab deruxtecan)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Oesophageal Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING